AddLife AB (publ) (LON:0REZ)
London
· Delayed Price · Currency is GBP · Price in SEK 153.19
-0.32 (-0.21%)
At close: Apr 22, 2025
AddLife AB Revenue
In the year 2024, AddLife AB had annual revenue of 10.29B SEK with 6.21% growth. AddLife AB had revenue of 2.82B in the quarter ending December 31, 2024, with 10.77% growth.
Revenue
10.29B SEK
Revenue Growth
+6.21%
P/S Ratio
2.02
Revenue / Employee
4.72M SEK
Employees
2,181
Market Cap
1.50B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.29B | 601.00M | 6.21% |
| Dec 31, 2023 | 9.69B | 601.00M | 6.62% |
| Dec 31, 2022 | 9.08B | 1.09B | 13.65% |
| Dec 31, 2021 | 7.99B | 2.72B | 51.57% |
| Dec 31, 2020 | 5.27B | 1.79B | 51.56% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
AddLife AB News
- 2 months ago - AddLife AB (FRA:1AD1) (Q4 2024) Earnings Call Highlights: Strong Finish with Robust Sales and ... - GuruFocus
- 2 months ago - Full Year 2024 AddLife AB Earnings Call Transcript - GuruFocus